Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide

P Pickkers1, R S Garcha, M Schachter

  • 1Department of Pharmacology, University Hospital Nijmegen, Nijmegen, The Netherlands.

Insights

Thiazide diuretics like hydrochlorothiazide relax blood vessels by inhibiting carbonic anhydrase, leading to calcium-activated potassium channel opening. This mechanism explains their direct vasodilator effects.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Molecular Biology

Background:

  • Hydrochlorothiazide (HCTZ) exhibits direct vasodilator effects via calcium-activated potassium (KCa) channels.
  • HCTZ inhibits carbonic anhydrase (CA), an enzyme sensitive to pH changes.
  • The role of CA in mediating HCTZ's vascular effects requires investigation.

Purpose of the Study:

  • To investigate the involvement of intracellular and extracellular carbonic anhydrase in the vascular actions of thiazide diuretics.
  • To determine if carbonic anhydrase inhibition is the primary mechanism behind hydrochlorothiazide's vasodilation.

Main Methods:

  • Small arteries from guinea pig mesentery were studied using a microvascular myograph.
  • Intracellular pH (pHi) and vascular tone were measured simultaneously.
  • Effects of hydrochlorothiazide, bendroflumethiazide, and carbonic anhydrase inhibitors were assessed with and without charybdotoxin (a KCa channel blocker).

Main Results:

  • Hydrochlorothiazide caused significant relaxation of noradrenaline-induced tone (74%), while bendroflumethiazide had minimal effect (16%).
  • Carbonic anhydrase inhibitors, including hydrochlorothiazide, relaxed tone concentration-dependently, an effect blocked by charybdotoxin.
  • Hydrochlorothiazide and acetazolamide increased pHi, correlating with vasodilation and KCa channel activation.

Conclusions:

  • The vasodilator effect of thiazide diuretics is primarily mediated by the inhibition of vascular smooth muscle cell carbonic anhydrase.
  • Inhibition of carbonic anhydrase leads to intracellular alkalinization, activating KCa channels and causing vasorelaxation.

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...